Skip to main content
. Author manuscript; available in PMC: 2020 Jan 10.
Published in final edited form as: J Invest Dermatol. 2008 Nov;128(11):2596–2605. doi: 10.1038/jid.2008.101

Figure 3. Response of a melanoma tumor to a lymphodepleting chemotherapy regimen combined with adoptive transfer of tumor-infiltrating T cells (Dudley et al., 2002a).

Figure 3.

(photo courtesy of Dr Steven A. Rosenberg, Surgery Branch, NCI).